메뉴 건너뛰기




Volumn 6, Issue 4, 2015, Pages 282-299

Metabolic risk factors of sporadic Alzheimer's disease: Implications in the pathology, pathogenesis and treatment

Author keywords

Alzheimer's disease; Metabolic; Pathogenesis; Risk factors; Sporadic; Treatment

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; VITAMIN D;

EID: 84937840738     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.002     Document Type: Review
Times cited : (110)

References (189)
  • 1
    • 79952574501 scopus 로고    scopus 로고
    • Epidemiology of Alzheimer disease
    • Reitz C, Brayne C, Mayeux R (2011). Epidemiology of Alzheimer disease, Nat Rev Neurol, 7:137-152.
    • (2011) Nat Rev Neurol , vol.7 , pp. 137-152
    • Reitz, C.1    Brayne, C.2    Mayeux, R.3
  • 4
    • 79952787104 scopus 로고    scopus 로고
    • Early-onset familial Alzheimer disease
    • Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. Seattle: NCBI
    • Bird TD (2012). Early-onset familial Alzheimer disease. In:Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews. Seattle: NCBI, 1-17.
    • (2012) GeneReviews , pp. 1-17
    • Bird, T.D.1
  • 5
    • 38449107280 scopus 로고    scopus 로고
    • Pathogenesis of Alzheimer's disease
    • Swerdlow RH (2007). Pathogenesis of Alzheimer's disease. Clin Interv Aging. 2:347-359.
    • (2007) Clin Interv Aging , vol.2 , pp. 347-359
    • Swerdlow, R.H.1
  • 6
    • 79953276681 scopus 로고    scopus 로고
    • The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis"
    • Armstrong RA (2011). The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis". Int J Alzheimers Dis, 2011:630865.
    • (2011) Int J Alzheimers Dis , vol.2011
    • Armstrong, R.A.1
  • 8
    • 3943092621 scopus 로고    scopus 로고
    • Pathways towards and away from Alzheimer's Disease
    • Mattson MP (2004). Pathways towards and away from Alzheimer's Disease. Nature, 430:631-639.
    • (2004) Nature , vol.430 , pp. 631-639
    • Mattson, M.P.1
  • 9
    • 70350432817 scopus 로고    scopus 로고
    • The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases
    • Lahiri DK, Maloney B, Zawia NH (2009). The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry, 14:992-1003.
    • (2009) Mol Psychiatry , vol.14 , pp. 992-1003
    • Lahiri, D.K.1    Maloney, B.2    Zawia, N.H.3
  • 10
    • 33846983823 scopus 로고    scopus 로고
    • How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD
    • Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH (2007). How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res, 4:219-228.
    • (2007) Curr Alzheimer Res , vol.4 , pp. 219-228
    • Lahiri, D.K.1    Maloney, B.2    Basha, M.R.3    Ge, Y.W.4    Zawia, N.H.5
  • 11
    • 77649339701 scopus 로고    scopus 로고
    • The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps
    • Lahiri DK, Maloney B (2010). The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps. Exp Gerontol, 45:291-296.
    • (2010) Exp Gerontol , vol.45 , pp. 291-296
    • Lahiri, D.K.1    Maloney, B.2
  • 12
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34:939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3    Katzman, R.4    Price, D.5    Stadlan, E.M.6
  • 15
    • 77952270949 scopus 로고    scopus 로고
    • Role of neuropsychological assessment in the differential diagnosis of Alzheimer's disease and vascular dementia
    • Pimmentel EML (2009). Role of neuropsychological assessment in the differential diagnosis of Alzheimer's disease and vascular dementia. Dement Neuropsychol, 3:214-221.
    • (2009) Dement Neuropsychol , vol.3 , pp. 214-221
    • Pimmentel, E.M.L.1
  • 16
    • 0036218738 scopus 로고    scopus 로고
    • Alzheimer disease as a vascular disorder: nosological evidence
    • de la Torre JC (2002).Alzheimer disease as a vascular disorder: nosological evidence. Stroke, 33:1152-1162.
    • (2002) Stroke , vol.33 , pp. 1152-1162
    • de la Torre, J.C.1
  • 17
    • 79956098248 scopus 로고    scopus 로고
    • Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease
    • Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7:280-292.
    • (2011) Alzheimers Dement , vol.7 , pp. 280-292
    • Sperling, R.A.1    Aisen, P.S.2    Beckett, L.A.3    Bennett, D.A.4    Craft, S.5    Fagan, A.M.6
  • 18
    • 79956084514 scopus 로고    scopus 로고
    • The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    • Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7:270-279.
    • (2011) Alzheimers Dement , vol.7 , pp. 270-279
    • Albert, M.S.1    DeKosky, S.T.2    Dickson, D.3    Dubois, B.4    Feldman, H.H.5    Fox, N.C.6
  • 19
    • 79956142378 scopus 로고    scopus 로고
    • The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    • McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al.(2011).The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7:263-269.
    • (2011) Alzheimers Dement , vol.7 , pp. 263-269
    • McKhann, G.M.1    Knopman, D.S.2    Chertkow, H.3    Hyman, B.T.4    Jack, C.R.5    Kawas, C.H.6
  • 20
    • 84856002055 scopus 로고    scopus 로고
    • National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
    • Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al. (2012).National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement., 8:1-13.
    • (2012) Alzheimers Dement , vol.8 , pp. 1-13
    • Hyman, B.T.1    Phelps, C.H.2    Beach, T.G.3    Bigio, E.H.4    Cairns, N.J.5    Carrillo, M.C.6
  • 22
    • 84857030932 scopus 로고    scopus 로고
    • National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
    • Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. (2012). National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol, 123:1-11.
    • (2012) Acta Neuropathol , vol.123 , pp. 1-11
    • Montine, T.J.1    Phelps, C.H.2    Beach, T.G.3    Bigio, E.H.4    Cairns, N.J.5    Dickson, D.W.6
  • 23
    • 0022414054 scopus 로고
    • Diagnosis of Alzheimer's Disease
    • Khachaturian ZS (1985). Diagnosis of Alzheimer's Disease. Arch Neurol, 42: 1097-1105.
    • (1985) Arch Neurol , vol.42 , pp. 1097-1105
    • Khachaturian, Z.S.1
  • 24
    • 0023924905 scopus 로고
    • Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases
    • Joachim CL, Morris JH, Selkoe DJ (1988). Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol, 24:50-56.
    • (1988) Ann Neurol , vol.24 , pp. 50-56
    • Joachim, C.L.1    Morris, J.H.2    Selkoe, D.J.3
  • 25
    • 0031255112 scopus 로고    scopus 로고
    • Editorial on Consensus Recommendations for the post-mortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the neuropathological assessment of Alzheimer Disease
    • Hyman BT, Trojanowski JQ (1997). Editorial on Consensus Recommendations for the post-mortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the neuropathological assessment of Alzheimer Disease. J Neuropathol Exp Neurol, 56:1095-1097.
    • (1997) J Neuropathol Exp Neurol , vol.56 , pp. 1095-1097
    • Hyman, B.T.1    Trojanowski, J.Q.2
  • 26
    • 84889090645 scopus 로고    scopus 로고
    • Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center
    • Serrano-Pozo A, Qian J, Monsell SE, Frosch MP, Betensky RA, Hyman BT (2013). Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol, 72: 1182-1192.
    • (2013) J Neuropathol Exp Neurol , vol.72 , pp. 1182-1192
    • Serrano-Pozo, A.1    Qian, J.2    Monsell, S.E.3    Frosch, M.P.4    Betensky, R.A.5    Hyman, B.T.6
  • 27
    • 84860215480 scopus 로고    scopus 로고
    • Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
    • Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. (2012). Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol, 71:362-381.
    • (2012) J Neuropathol Exp Neurol , vol.71 , pp. 362-381
    • Nelson, P.T.1    Alafuzoff, I.2    Bigio, E.H.3    Bouras, C.4    Braak, H.5    Cairns, N.J.6
  • 28
    • 84888204549 scopus 로고    scopus 로고
    • Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis
    • Dong S, Duan Y, Hu Y, Zhao Z (2012). Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis. Transl Neurodegener, 1:1-18.
    • (2012) Transl Neurodegener , vol.1 , pp. 1-18
    • Dong, S.1    Duan, Y.2    Hu, Y.3    Zhao, Z.4
  • 30
    • 0036736218 scopus 로고    scopus 로고
    • Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease
    • Suh YH, Checler F (2002). Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev, 54:469-525.
    • (2002) Pharmacol Rev , vol.54 , pp. 469-525
    • Suh, Y.H.1    Checler, F.2
  • 31
    • 84866530316 scopus 로고    scopus 로고
    • Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides
    • Bali J, Gheinani AH, Zurbriggen S, Rajendran L (2012). Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides. Proc Natl Acad Sci USA, 109:15307-15311.
    • (2012) Proc Natl Acad Sci USA , vol.109 , pp. 15307-15311
    • Bali, J.1    Gheinani, A.H.2    Zurbriggen, S.3    Rajendran, L.4
  • 33
    • 12344323961 scopus 로고    scopus 로고
    • Tau phosphorylation in neuronal cell function and dysfunction
    • Johnson GV, Stoothoff WH (2004).Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci, 117:5721-5729.
    • (2004) J Cell Sci , vol.117 , pp. 5721-5729
    • Johnson, G.V.1    Stoothoff, W.H.2
  • 34
    • 33747036919 scopus 로고    scopus 로고
    • Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics
    • Butterfield DA, Perluigi M, Sultana R (2006). Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol, 545:39-50.
    • (2006) Eur J Pharmacol , vol.545 , pp. 39-50
    • Butterfield, D.A.1    Perluigi, M.2    Sultana, R.3
  • 35
    • 84881525560 scopus 로고    scopus 로고
    • Oxidative stress and the pathogenesis of Alzheimer's disease
    • Zhao Y, Zhao B (2013). Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev, 2013:316523.
    • (2013) Oxid Med Cell Longev , vol.2013
    • Zhao, Y.1    Zhao, B.2
  • 36
    • 84887892331 scopus 로고    scopus 로고
    • Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants
    • Chakrabarti S, Sinha M, Thakurta IG, Banerjee P, Chattopadhyay M (2013). Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants. Curr Med Chem, 20: 4648-4664.
    • (2013) Curr Med Chem , vol.20 , pp. 4648-4664
    • Chakrabarti, S.1    Sinha, M.2    Thakurta, I.G.3    Banerjee, P.4    Chattopadhyay, M.5
  • 37
    • 77956199031 scopus 로고    scopus 로고
    • A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease
    • Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, et al. (2010). A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J Alzheimers Dis, 20: S401-S412.
    • (2010) J Alzheimers Dis , vol.20 , pp. S401-S412
    • Santos, R.X.1    Correia, S.C.2    Wang, X.3    Perry, G.4    Smith, M.A.5    Moreira, P.I.6
  • 38
    • 33748283747 scopus 로고    scopus 로고
    • Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction
    • Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK (2010). Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci, 26:9057-9068.
    • (2010) J Neurosci , vol.26 , pp. 9057-9068
    • Devi, L.1    Prabhu, B.M.2    Galati, D.F.3    Avadhani, N.G.4    Anandatheerthavarada, H.K.5
  • 40
    • 84875655895 scopus 로고    scopus 로고
    • Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature
    • Wyss-Coray T, Rogers J (2012). Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med, 2:a006346.
    • (2012) Cold Spring Harb Perspect Med , vol.2
    • Wyss-Coray, T.1    Rogers, J.2
  • 41
    • 57149123424 scopus 로고    scopus 로고
    • Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology
    • Salminen A, Ojala J, Suuronen T, Kaarniranta K, Kauppinen A (2008). Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med, 12:2255-2262.
    • (2008) J Cell Mol Med , vol.12 , pp. 2255-2262
    • Salminen, A.1    Ojala, J.2    Suuronen, T.3    Kaarniranta, K.4    Kauppinen, A.5
  • 42
    • 84896324370 scopus 로고    scopus 로고
    • The role of inflammasome in Alzheimer's disease
    • Liu L, Chan C (2014). The role of inflammasome in Alzheimer's disease. Ageing Res Rev, 15:6-15.
    • (2014) Ageing Res Rev , vol.15 , pp. 6-15
    • Liu, L.1    Chan, C.2
  • 43
    • 57649187117 scopus 로고    scopus 로고
    • Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease
    • Mosconi L, Pupi A, De Leon MJ (2008). Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci, 1147:180-195.
    • (2008) Ann N Y Acad Sci , vol.1147 , pp. 180-195
    • Mosconi, L.1    Pupi, A.2    De Leon, M.J.3
  • 44
    • 84865613285 scopus 로고    scopus 로고
    • Sporadic Alzheimer's disease: the starving brain
    • Mamelak M (2012). Sporadic Alzheimer's disease: the starving brain. J Alzheimers Dis, 31:459-474.
    • (2012) J Alzheimers Dis , vol.31 , pp. 459-474
    • Mamelak, M.1
  • 45
    • 47849121436 scopus 로고    scopus 로고
    • An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease
    • Erol A (2008). An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease. J Alzheimers Dis, 13:241-253.
    • (2008) J Alzheimers Dis , vol.13 , pp. 241-253
    • Erol, A.1
  • 46
    • 84897954482 scopus 로고    scopus 로고
    • Brain metabolic dysfunction at the core of Alzheimer's disease
    • de la Monte SM, Tong M (2014). Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol, 88:548-559.
    • (2014) Biochem Pharmacol , vol.88 , pp. 548-559
    • de la Monte, S.M.1    Tong, M.2
  • 51
    • 0031737226 scopus 로고    scopus 로고
    • Abnormalities of mitochondrial enzymes in Alzheimer disease
    • Gibson GE1, Sheu KF, Blass JP (1998). Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm, 105:855-870.
    • (1998) J Neural Transm , vol.105 , pp. 855-870
    • Gibson, G.E.1    Sheu, K.F.2    Blass, J.P.3
  • 53
    • 84895068306 scopus 로고    scopus 로고
    • Reevaluating metabolism in Alzheimer's disease from the perspective of the astrocyte-neuron lactate shuttle model
    • Newington JT, Harris RA, Cumming RC (2013). Reevaluating metabolism in Alzheimer's disease from the perspective of the astrocyte-neuron lactate shuttle model. J Neurodeg Dis, 2013: 234572.
    • (2013) J Neurodeg Dis , vol.2013
    • Newington, J.T.1    Harris, R.A.2    Cumming, R.C.3
  • 54
    • 78650122129 scopus 로고    scopus 로고
    • Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease
    • Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D (2010). Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev, 9:399-417.
    • (2010) Ageing Res Rev , vol.9 , pp. 399-417
    • Frisardi, V.1    Solfrizzi, V.2    Seripa, D.3    Capurso, C.4    Santamato, A.5    Sancarlo, D.6
  • 55
    • 78649498680 scopus 로고    scopus 로고
    • Apolipoprotein E e4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis
    • Crean S, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL, et al. (2011). Apolipoprotein E e4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis. Dement Geriatr Cogn Disord, 31:20-30.
    • (2011) Dement Geriatr Cogn Disord , vol.31 , pp. 20-30
    • Crean, S.1    Ward, A.2    Mercaldi, C.J.3    Collins, J.M.4    Cook, M.N.5    Baker, N.L.6
  • 56
    • 2442684094 scopus 로고    scopus 로고
    • Cholesterol and APOE genotype interact to influence Alzheimer disease progression
    • Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J and Farlow MR (2004). Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology, 62:1869-1871.
    • (2004) Neurology , vol.62 , pp. 1869-1871
    • Evans, R.M.1    Hui, S.2    Perkins, A.3    Lahiri, D.K.4    Poirier, J.5    Farlow, M.R.6
  • 58
    • 0035897938 scopus 로고    scopus 로고
    • Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
    • Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. (2001). Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ, 322:1447-1451.
    • (2001) BMJ , vol.322 , pp. 1447-1451
    • Kivipelto, M.1    Helkala, E.L.2    Laakso, M.P.3    Hanninen, T.4    Hallikainen, M.5    Alhainen, K.6
  • 59
    • 67749114631 scopus 로고    scopus 로고
    • Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later
    • Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA (2009). Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord, 28:75-80.
    • (2009) Dement Geriatr Cogn Disord , vol.28 , pp. 75-80
    • Solomon, A.1    Kivipelto, M.2    Wolozin, B.3    Zhou, J.4    Whitmer, R.A.5
  • 60
    • 0033958076 scopus 로고    scopus 로고
    • Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans
    • Evans RM, Emsley CL, Gao S, Sahota A, Hall KS, Farlow MR, et al (2000). Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology, 54:240-242.
    • (2000) Neurology , vol.54 , pp. 240-242
    • Evans, R.M.1    Emsley, C.L.2    Gao, S.3    Sahota, A.4    Hall, K.S.5    Farlow, M.R.6
  • 61
    • 80053928598 scopus 로고    scopus 로고
    • Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies
    • Shepardson NE, Shankar GM, Selkoe DJ (2011). Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol, 68:1239-1244.
    • (2011) Arch Neurol , vol.68 , pp. 1239-1244
    • Shepardson, N.E.1    Shankar, G.M.2    Selkoe, D.J.3
  • 62
    • 80054924950 scopus 로고    scopus 로고
    • Mild hypercholesterolemia, normal plasma triglycerides, and normal glucose levels across dementia staging in Alzheimer's disease: a clinical setting-based retrospective study
    • Ramdane S, Daoudi-Gueddah D (2011). Mild hypercholesterolemia, normal plasma triglycerides, and normal glucose levels across dementia staging in Alzheimer's disease: a clinical setting-based retrospective study. Am J Alzheimers Dis Other Demen, 26:399-405.
    • (2011) Am J Alzheimers Dis Other Demen , vol.26 , pp. 399-405
    • Ramdane, S.1    Daoudi-Gueddah, D.2
  • 64
    • 78650001684 scopus 로고    scopus 로고
    • The 32-year relationship between cholesterol and dementia from midlife to late life
    • Mielke MM, Zandi PP, Shao H, Waern M, Östling S, Guo X, et al. (2010). The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology, 75:1888-1895.
    • (2010) Neurology , vol.75 , pp. 1888-1895
    • Mielke, M.M.1    Zandi, P.P.2    Shao, H.3    Waern, M.4    Östling, S.5    Guo, X.6
  • 65
    • 79953733579 scopus 로고    scopus 로고
    • Plasma cholesterol and risk for late-onset Alzheimer's disease
    • Cedazo-Mínguez A, Ismail MA, Mateos L (2011). Plasma cholesterol and risk for late-onset Alzheimer's disease. Expert Rev Neurother, 11:495-498.
    • (2011) Expert Rev Neurother , vol.11 , pp. 495-498
    • Cedazo-Mínguez, A.1    Ismail, M.A.2    Mateos, L.3
  • 66
    • 18844457544 scopus 로고    scopus 로고
    • High total cholesterol levels in late life associated with a reduced risk of dementia
    • Mielke MM, Zandi PP, Sjögren M, Gustafson D, Ostling S, Steen B et al. (2005). High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology, 64:1689-1695.
    • (2005) Neurology , vol.64 , pp. 1689-1695
    • Mielke, M.M.1    Zandi, P.P.2    Sjögren, M.3    Gustafson, D.4    Ostling, S.5    Steen, B.6
  • 67
    • 0033772113 scopus 로고    scopus 로고
    • Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
    • Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol, 57:1439-1443.
    • (2000) Arch Neurol , vol.57 , pp. 1439-1443
    • Wolozin, B.1    Kellman, W.2    Ruosseau, P.3    Celesia, G.G.4    Siegel, G.5
  • 68
    • 84921537471 scopus 로고    scopus 로고
    • Statins for the prevention of Alzheimer's disease
    • Scott HD, Laake K (2001). Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev, 4:CD003160.
    • (2001) Cochrane Database Syst Rev , vol.4
    • Scott, H.D.1    Laake, K.2
  • 69
    • 81355164295 scopus 로고    scopus 로고
    • Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations
    • Shepardson NE, Shankar GM, Selkoe DJ (2011). Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol, 68:1385-1392.
    • (2011) Arch Neurol , vol.68 , pp. 1385-1392
    • Shepardson, N.E.1    Shankar, G.M.2    Selkoe, D.J.3
  • 70
    • 0035826795 scopus 로고    scopus 로고
    • A fluid connection: cholesterol and Abeta
    • Wolozin B (2001). A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci USA, 98:5371-5373.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 5371-5373
    • Wolozin, B.1
  • 71
    • 0345669752 scopus 로고    scopus 로고
    • Alzheimer's disease: the cholesterol connection
    • Puglielli L, Tanzi RE, Kovacs DM (2003). Alzheimer's disease: the cholesterol connection. Nat Neurosci. 6:345-351.
    • (2003) Nat Neurosci , vol.6 , pp. 345-351
    • Puglielli, L.1    Tanzi, R.E.2    Kovacs, D.M.3
  • 72
    • 84866687889 scopus 로고    scopus 로고
    • Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice
    • Umeda T, Tomiyama T, Kitajima E, Idomoto T, Nomura S, Lambert MP, et al. (2012). Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice. Life Sci, 91:1169-1176.
    • (2012) Life Sci , vol.91 , pp. 1169-1176
    • Umeda, T.1    Tomiyama, T.2    Kitajima, E.3    Idomoto, T.4    Nomura, S.5    Lambert, M.P.6
  • 73
    • 2442557294 scopus 로고    scopus 로고
    • Brain cholesterol: long secret life behind a barrier
    • Bjorkhem I, Meaney S (2004). Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol, 24:806-815.
    • (2004) Arterioscler Thromb Vasc Biol , vol.24 , pp. 806-815
    • Bjorkhem, I.1    Meaney, S.2
  • 74
    • 0035083555 scopus 로고    scopus 로고
    • Cholesterol metabolism in the brain
    • Dietschy JM, Turley SD (2001). Cholesterol metabolism in the brain. Curr Opin Lipidol, 12:105-112.
    • (2001) Curr Opin Lipidol , vol.12 , pp. 105-112
    • Dietschy, J.M.1    Turley, S.D.2
  • 75
    • 0035949755 scopus 로고    scopus 로고
    • Cholesterol and Alzheimer's disease: is there a link?
    • Simons M, Keller P, Dichgans J, Schulz JB (2001). Cholesterol and Alzheimer's disease: is there a link? Neurology, 57:1089-1093.
    • (2001) Neurology , vol.57 , pp. 1089-1093
    • Simons, M.1    Keller, P.2    Dichgans, J.3    Schulz, J.B.4
  • 76
    • 0033968648 scopus 로고    scopus 로고
    • Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture
    • Michikawa M, Fan QW, Isobe I, Yanagisawa K (2000). Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem, 74:1008-1016.
    • (2000) J Neurochem , vol.74 , pp. 1008-1016
    • Michikawa, M.1    Fan, Q.W.2    Isobe, I.3    Yanagisawa, K.4
  • 77
    • 2442684094 scopus 로고    scopus 로고
    • Cholesterol and APOE genotype interact to influence Alzheimer disease progression
    • Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J, Farlow MR (2004). Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology, 62:1869-1871.
    • (2004) Neurology , vol.62 , pp. 1869-1871
    • Evans, R.M.1    Hui, S.2    Perkins, A.3    Lahiri, D.K.4    Poirier, J.5    Farlow, M.R.6
  • 78
    • 80053557887 scopus 로고    scopus 로고
    • Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study
    • Zuliani G, Donnorso MP, Bosi C, Passaro A, Dalla Nora E, Zurlo A, et al. (2011). Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study. BMC Neurol, 11:121.
    • (2011) BMC Neurol , vol.11 , pp. 121
    • Zuliani, G.1    Donnorso, M.P.2    Bosi, C.3    Passaro, A.4    Dalla Nora, E.5    Zurlo, A.6
  • 79
    • 0037388527 scopus 로고    scopus 로고
    • Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease
    • Vega GL, Weiner MF, Lipton AM, Von Bergmann K, Lutjohann D, Moore C, et al. (2003). Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol, 60:510-515.
    • (2003) Arch Neurol , vol.60 , pp. 510-515
    • Vega, G.L.1    Weiner, M.F.2    Lipton, A.M.3    Von Bergmann, K.4    Lutjohann, D.5    Moore, C.6
  • 80
    • 0031050268 scopus 로고    scopus 로고
    • Risk of dementia among persons with diabetes mellitus: a population-based cohort study
    • Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, et al. (1997). Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol, 145:301-308.
    • (1997) Am J Epidemiol , vol.145 , pp. 301-308
    • Leibson, C.L.1    Rocca, W.A.2    Hanson, V.A.3    Cha, R.4    Kokmen, E.5    O'Brien, P.C.6
  • 83
    • 0036227542 scopus 로고    scopus 로고
    • Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study
    • Peila R, Rodriguez BL, Launer LJ (2002). Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes, 51:1256-1262.
    • (2002) Diabetes , vol.51 , pp. 1256-1262
    • Peila, R.1    Rodriguez, B.L.2    Launer, L.J.3
  • 84
    • 36448936053 scopus 로고    scopus 로고
    • Common pathological processes in Alzheimer disease and type 2 diabetes: a review
    • Li L, Holscher C (2007). Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev, 56:384-402.
    • (2007) Brain Res Rev , vol.56 , pp. 384-402
    • Li, L.1    Holscher, C.2
  • 85
  • 86
  • 87
    • 84861450111 scopus 로고    scopus 로고
    • Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
    • Cheng G, Huang C, Deng H, Wang H (2012). Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J, 42:484-491.
    • (2012) Intern Med J , vol.42 , pp. 484-491
    • Cheng, G.1    Huang, C.2    Deng, H.3    Wang, H.4
  • 88
    • 84867711808 scopus 로고    scopus 로고
    • An update on type 2 diabetes, vascular dementia and Alzheimer's disease
    • Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012). An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol, 47:858-864.
    • (2012) Exp Gerontol , vol.47 , pp. 858-864
    • Exalto, L.G.1    Whitmer, R.A.2    Kappele, L.J.3    Biessels, G.J.4
  • 89
    • 84874455392 scopus 로고    scopus 로고
    • Type 2 diabetes as a risk factor for Alzheimer's disease: The confounders, interactions, and neuropathology associated with this relationship
    • Vagelatos NT, Eslick GD (2013). Type 2 diabetes as a risk factor for Alzheimer's disease: The confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev, 35:152-160.
    • (2013) Epidemiol Rev , vol.35 , pp. 152-160
    • Vagelatos, N.T.1    Eslick, G.D.2
  • 90
    • 78649510282 scopus 로고    scopus 로고
    • Diabetes, related conditions, and dementia
    • Luchsinger JA (2010). Diabetes, related conditions, and dementia. J Neurol Sci, 299:35-38.
    • (2010) J Neurol Sci , vol.299 , pp. 35-38
    • Luchsinger, J.A.1
  • 91
    • 9844229370 scopus 로고    scopus 로고
    • Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study
    • Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, et al. (1997). Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ, 315:1045-1049.
    • (1997) BMJ , vol.315 , pp. 1045-1049
    • Kuusisto, J.1    Koivisto, K.2    Mykkanen, L.3    Helkala, E.L.4    Vanhanen, M.5    Hanninen, T.6
  • 94
    • 84862280143 scopus 로고    scopus 로고
    • Diabetes and cognitive dysfunction
    • McCrimmon RJ, Ryan CM, Frier BM (2012). Diabetes and cognitive dysfunction. Lancet, 379:2291-2299.
    • (2012) Lancet , vol.379 , pp. 2291-2299
    • McCrimmon, R.J.1    Ryan, C.M.2    Frier, B.M.3
  • 95
    • 0030680107 scopus 로고    scopus 로고
    • Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective post-mortem immunocytochemical and histofluorescent study
    • Heitner J, Dickson D (1997). Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective post-mortem immunocytochemical and histofluorescent study. Neurology, 49:1306-1311.
    • (1997) Neurology , vol.49 , pp. 1306-1311
    • Heitner, J.1    Dickson, D.2
  • 96
    • 77957940731 scopus 로고    scopus 로고
    • Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study
    • Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B et al (2010). Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology, 75:1195-1202.
    • (2010) Neurology , vol.75 , pp. 1195-1202
    • Ahtiluoto, S.1    Polvikoski, T.2    Peltonen, M.3    Solomon, A.4    Tuomilehto, J.5    Winblad, B.6
  • 98
    • 84873395982 scopus 로고    scopus 로고
    • Alzheimer's disease and insulin resistance: translating basic science into clinical applications
    • De Felice FG (2013). Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J Clin Invest, 123:531-539.
    • (2013) J Clin Invest , vol.123 , pp. 531-539
    • De Felice, F.G.1
  • 99
    • 0035871641 scopus 로고    scopus 로고
    • Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling
    • Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, et al (2001). Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci, 21:2561-2570.
    • (2001) J Neurosci , vol.21 , pp. 2561-2570
    • Gasparini, L.1    Gouras, G.K.2    Wang, R.3    Gross, R.S.4    Beal, M.F.5    Greengard, P.6
  • 100
    • 84870213683 scopus 로고    scopus 로고
    • Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway
    • Son SM, Song H, Byun J, Park KS, Jang HC, Park YJ, Mook-Jung I (2012). Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway. Diabetes, 61:3126-3138.
    • (2012) Diabetes , vol.61 , pp. 3126-3138
    • Son, S.M.1    Song, H.2    Byun, J.3    Park, K.S.4    Jang, H.C.5    Park, Y.J.6    Mook-Jung, I.7
  • 101
    • 84857788978 scopus 로고    scopus 로고
    • Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation
    • Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS, et al (2012). Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation. Brain Res, 1441:64-78.
    • (2012) Brain Res , vol.1441 , pp. 64-78
    • Correia, S.C.1    Santos, R.X.2    Carvalho, C.3    Cardoso, S.4    Candeias, E.5    Santos, M.S.6
  • 102
    • 84883733870 scopus 로고    scopus 로고
    • Molecular links between Alzheimer's disease and diabetes mellitus
    • Yang Y, Song W (2013). Molecular links between Alzheimer's disease and diabetes mellitus. Neuroscience, 250: 140-150.
    • (2013) Neuroscience , vol.250 , pp. 140-150
    • Yang, Y.1    Song, W.2
  • 103
    • 84879256567 scopus 로고    scopus 로고
    • When aging-onset diabetes is coming across with Alzheimer disease: comparable pathogenesis and therapy
    • Tang J, Pei Y, Zhou G (2013). When aging-onset diabetes is coming across with Alzheimer disease: comparable pathogenesis and therapy. Exp Gerontol, 48:744-750.
    • (2013) Exp Gerontol , vol.48 , pp. 744-750
    • Tang, J.1    Pei, Y.2    Zhou, G.3
  • 104
    • 79960896430 scopus 로고    scopus 로고
    • Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
    • Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011). Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J. Pathol, 225:54-62.
    • (2011) J. Pathol , vol.225 , pp. 54-62
    • Liu, Y.1    Liu, F.2    Grundke-Iqbal, I.3    Iqbal, K.4    Gong, C.X.5
  • 106
    • 33644591150 scopus 로고    scopus 로고
    • Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer'sdisease: link to brain reductions in acetylcholine
    • Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005). Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer'sdisease: link to brain reductions in acetylcholine. J Alzheimers Dis, 8:247-268.
    • (2005) J Alzheimers Dis , vol.8 , pp. 247-268
    • Rivera, E.J.1    Goldin, A.2    Fulmer, N.3    Tavares, R.4    Wands, J.R.5    de la Monte, S.M.6
  • 107
    • 15244351255 scopus 로고    scopus 로고
    • Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?
    • Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. (2005). Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis. 7:63-80.
    • (2005) J Alzheimers Dis , vol.7 , pp. 63-80
    • Steen, E.1    Terry, B.M.2    Rivera, E.J.3    Cannon, J.L.4    Neely, T.R.5    Tavares, R.6
  • 108
    • 34247324303 scopus 로고    scopus 로고
    • Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein
    • Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007). Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem, 101: 757-770.
    • (2007) J Neurochem , vol.101 , pp. 757-770
    • Grunblatt, E.1    Salkovic-Petrisic, M.2    Osmanovic, J.3    Riederer, P.4    Hoyer, S.5
  • 109
    • 4644286910 scopus 로고    scopus 로고
    • Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease
    • Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, et al. (2004). Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J, 18:902-904.
    • (2004) FASEB J , vol.18 , pp. 902-904
    • Ho, L.1    Qin, W.2    Pompl, P.N.3    Xiang, Z.4    Wang, J.5    Zhao, Z.6
  • 110
    • 79956359796 scopus 로고    scopus 로고
    • A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models
    • Park SA (2011). A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models. J Clin Neurol, 7:10-18.
    • (2011) J Clin Neurol , vol.7 , pp. 10-18
    • Park, S.A.1
  • 112
    • 79960555700 scopus 로고    scopus 로고
    • Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis
    • Bosco D, Fava A, Plastino M, Montalcini T, Pujia A (2011). Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med, 15:1807-1821.
    • (2011) J Cell Mol Med , vol.15 , pp. 1807-1821
    • Bosco, D.1    Fava, A.2    Plastino, M.3    Montalcini, T.4    Pujia, A.5
  • 113
    • 84880555817 scopus 로고    scopus 로고
    • Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence
    • Freiherr J, Hallschmid M, Frey WH 2nd, Brünner YF, Chapman CD, Holscher C, et al. (2013). Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. CNS Drugs, 27:505-514.
    • (2013) CNS Drugs , vol.27 , pp. 505-514
    • Freiherr, J.1    Hallschmid, M.2    Frey, W.H.3    Brünner, Y.F.4    Chapman, C.D.5    Holscher, C.6
  • 114
    • 84864921644 scopus 로고    scopus 로고
    • Insulin resistance in the brain: an old-age or new-age problem?
    • Williamson R, McNeilly A, Sutherland C (2012). Insulin resistance in the brain: an old-age or new-age problem? Biochem Pharmacol, 84:737-745.
    • (2012) Biochem Pharmacol , vol.84 , pp. 737-745
    • Williamson, R.1    McNeilly, A.2    Sutherland, C.3
  • 115
    • 77950787113 scopus 로고    scopus 로고
    • Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction
    • Ciaccio M, Bellia C (2010). Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction. Curr Clin Pharmacol, 5:30-36.
    • (2010) Curr Clin Pharmacol , vol.5 , pp. 30-36
    • Ciaccio, M.1    Bellia, C.2
  • 116
    • 67650753876 scopus 로고    scopus 로고
    • The treatment of hyperhomocysteinemia
    • Maron BA, Loscalzo J (2009). The treatment of hyperhomocysteinemia. Annu Rev Med. 60:39-54.
    • (2009) Annu Rev Med , vol.60 , pp. 39-54
    • Maron, B.A.1    Loscalzo, J.2
  • 117
    • 80052024330 scopus 로고    scopus 로고
    • Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?
    • Zhuo JM, Wang H, Pratico D (2011). Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci, 32:562-571.
    • (2011) Trends Pharmacol Sci , vol.32 , pp. 562-571
    • Zhuo, J.M.1    Wang, H.2    Pratico, D.3
  • 121
    • 79960759869 scopus 로고    scopus 로고
    • Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants
    • Wald DS, Kasturiratne A, Simmonds M (2011). Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement. 7:412-417.
    • (2011) Alzheimers Dement , vol.7 , pp. 412-417
    • Wald, D.S.1    Kasturiratne, A.2    Simmonds, M.3
  • 122
    • 0031597388 scopus 로고    scopus 로고
    • Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
    • Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol, 55:1449-1455.
    • (1998) Arch Neurol , vol.55 , pp. 1449-1455
    • Clarke, R.1    Smith, A.D.2    Jobst, K.A.3    Refsum, H.4    Sutton, L.5    Ueland, P.M.6
  • 123
    • 8544219697 scopus 로고    scopus 로고
    • Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel
    • Mizrahi EH, Bowirrat A, Jacobsen DW, Korczyn AD, Traore F, Petot GJ, et al. (2004). Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel. J Neurol Sci, 227:109-113.
    • (2004) J Neurol Sci , vol.227 , pp. 109-113
    • Mizrahi, E.H.1    Bowirrat, A.2    Jacobsen, D.W.3    Korczyn, A.D.4    Traore, F.5    Petot, G.J.6
  • 124
    • 0035205173 scopus 로고    scopus 로고
    • Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study
    • Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G (2001). Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology, 47:324-329.
    • (2001) Gerontology , vol.47 , pp. 324-329
    • Postiglione, A.1    Milan, G.2    Ruocco, A.3    Gallotta, G.4    Guiotto, G.5    Di Minno, G.6
  • 125
    • 84866482141 scopus 로고    scopus 로고
    • Elevated plasma homocysteine level is not primarily related to Alzheimer's disease
    • Nilsson K, Gustafson L, Hultberg B (2012). Elevated plasma homocysteine level is not primarily related to Alzheimer's disease. Dement Geriatr Cogn Disord, 34:121-127.
    • (2012) Dement Geriatr Cogn Disord , vol.34 , pp. 121-127
    • Nilsson, K.1    Gustafson, L.2    Hultberg, B.3
  • 126
    • 33747391975 scopus 로고    scopus 로고
    • Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease?
    • Seshadri S (2006). Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimers Dis, 9:393-398.
    • (2006) J Alzheimers Dis , vol.9 , pp. 393-398
    • Seshadri, S.1
  • 127
    • 54049106963 scopus 로고    scopus 로고
    • High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
    • Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, et al. (2008). High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA, 300: 1774-1783.
    • (2008) JAMA , vol.300 , pp. 1774-1783
    • Aisen, P.S.1    Schneider, L.S.2    Sano, M.3    Diaz-Arrastia, R.4    van Dyck, C.H.5    Weiner, M.F.6
  • 128
    • 36249003381 scopus 로고    scopus 로고
    • Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients
    • Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC (2007). Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther, 29:2204-2214.
    • (2007) Clin Ther , vol.29 , pp. 2204-2214
    • Sun, Y.1    Lu, C.J.2    Chien, K.L.3    Chen, S.T.4    Chen, R.C.5
  • 129
  • 130
    • 84890521380 scopus 로고    scopus 로고
    • Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia
    • Ray L, Khemka VK, Behera P, Bandyopadhyay K, Pal S, Pal K, et al. (2013).Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia. Aging Dis, 4:57-64.
    • (2013) Aging Dis , vol.4 , pp. 57-64
    • Ray, L.1    Khemka, V.K.2    Behera, P.3    Bandyopadhyay, K.4    Pal, S.5    Pal, K.6
  • 131
    • 33646747001 scopus 로고    scopus 로고
    • Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia
    • Obeid R, Herrmann W (2006). Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett, 580:2994-3005.
    • (2006) FEBS Lett , vol.580 , pp. 2994-3005
    • Obeid, R.1    Herrmann, W.2
  • 132
    • 84899436522 scopus 로고    scopus 로고
    • Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro
    • Lin N, Qin S, Luo S, Cui S, Huang G, Zhang X (2014). Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro. FEBS J, 281:2088-2096.
    • (2014) FEBS J , vol.281 , pp. 2088-2096
    • Lin, N.1    Qin, S.2    Luo, S.3    Cui, S.4    Huang, G.5    Zhang, X.6
  • 133
    • 0030604041 scopus 로고    scopus 로고
    • Involvement of N-methyl-d-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture
    • Kim WK, Pae YS (1996). Involvement of N-methyl-d-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett, 216:117-120.
    • (1996) Neurosci Lett , vol.216 , pp. 117-120
    • Kim, W.K.1    Pae, Y.S.2
  • 135
    • 0036851817 scopus 로고    scopus 로고
    • Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
    • Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 8:1288-1295.
    • (2002) Nat Med , vol.8 , pp. 1288-1295
    • Yamauchi, T.1    Kamon, J.2    Minokoshi, Y.3    Ito, Y.4    Waki, H.5    Uchida, S.6
  • 136
    • 9144235551 scopus 로고    scopus 로고
    • Adiponectin and leptin in relation to insulin sensitivity
    • Soodini GR (2004). Adiponectin and leptin in relation to insulin sensitivity. Metab Syndr Relat Disord, 2:114-123.
    • (2004) Metab Syndr Relat Disord , vol.2 , pp. 114-123
    • Soodini, G.R.1
  • 138
    • 34548362074 scopus 로고    scopus 로고
    • Hypothalamic leptin regulation of energy homeostasis and glucose metabolism
    • Morton GJ (2007). Hypothalamic leptin regulation of energy homeostasis and glucose metabolism. J Physiol, 583:437-443.
    • (2007) J Physiol , vol.583 , pp. 437-443
    • Morton, G.J.1
  • 139
    • 84980052298 scopus 로고    scopus 로고
    • Leptin signaling and Alzheimer's disease
    • Marwarha G, Ghribi O (2012). Leptin signaling and Alzheimer's disease. Am J Neurodegener Dis, 1:245-265.
    • (2012) Am J Neurodegener Dis , vol.1 , pp. 245-265
    • Marwarha, G.1    Ghribi, O.2
  • 140
    • 84255175411 scopus 로고    scopus 로고
    • Obesity, leptin, and Alzheimer's disease
    • Lee EB (2011). Obesity, leptin, and Alzheimer's disease. Ann N Y Acad Sci, 1243:15-29.
    • (2011) Ann N Y Acad Sci , vol.1243 , pp. 15-29
    • Lee, E.B.1
  • 141
    • 72549091935 scopus 로고    scopus 로고
    • Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging
    • Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, et al. (2009). Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA, 302:2565-2572.
    • (2009) JAMA , vol.302 , pp. 2565-2572
    • Lieb, W.1    Beiser, A.S.2    Vasan, R.S.3    Tan, Z.S.4    Au, R.5    Harris, T.B.6
  • 144
    • 79958808000 scopus 로고    scopus 로고
    • Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease
    • Une K, Takei YA, Tomita N, Asamura T, Ohrui T, Furukawa K, et al. (2011). Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. Eur J Neurol, 18:1006-1009.
    • (2011) Eur J Neurol , vol.18 , pp. 1006-1009
    • Une, K.1    Takei, Y.A.2    Tomita, N.3    Asamura, T.4    Ohrui, T.5    Furukawa, K.6
  • 145
    • 84860903756 scopus 로고    scopus 로고
    • Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study
    • van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, et al. (2012). Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch Neurol, 69:594-600.
    • (2012) Arch Neurol , vol.69 , pp. 594-600
    • van Himbergen, T.M.1    Beiser, A.S.2    Ai, M.3    Seshadri, S.4    Otokozawa, S.5    Au, R.6
  • 146
    • 84863229451 scopus 로고    scopus 로고
    • Lipids and adipokines as risk factors for Alzheimer's disease
    • Warren MW, Hynan LS, Weiner MF (2012). Lipids and adipokines as risk factors for Alzheimer's disease. J Alzheimers Dis, 29:151-157.
    • (2012) J Alzheimers Dis , vol.29 , pp. 151-157
    • Warren, M.W.1    Hynan, L.S.2    Weiner, M.F.3
  • 148
    • 84155162481 scopus 로고    scopus 로고
    • Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
    • Smith JA, Das A, Ray SK, Banik NL (2012). Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain res bull, 87:10-20.
    • (2012) Brain res bull , vol.87 , pp. 10-20
    • Smith, J.A.1    Das, A.2    Ray, S.K.3    Banik, N.L.4
  • 149
    • 84879398619 scopus 로고    scopus 로고
    • Is there a causal link between Inflammation and dementia?
    • Enciu AM, Popescu BO (2013). Is there a causal link between Inflammation and dementia? Biomed Res Int, 2013:316495.
    • (2013) Biomed Res Int , vol.2013
    • Enciu, A.M.1    Popescu, B.O.2
  • 151
    • 33947727192 scopus 로고    scopus 로고
    • Interleukins, inflammation, and mechanisms of Alzheimer's disease
    • Weisman D, Hakimian E, and Ho GJ (2006). Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitam Horm, 74:505-530.
    • (2006) Vitam Horm , vol.74 , pp. 505-530
    • Weisman, D.1    Hakimian, E.2    Ho, G.J.3
  • 152
    • 84861078831 scopus 로고    scopus 로고
    • A review: Inflammatory process in Alzheimer's disease, Role of cytokines
    • Rubio-Perez JM and Morillas-Ruiz JM (2012). A review: Inflammatory process in Alzheimer's disease, Role of cytokines. Scientific World Journal, 2012: 756357.
    • (2012) Scientific World Journal , vol.2012
    • Rubio-Perez, J.M.1    Morillas-Ruiz, J.M.2
  • 153
    • 84873087532 scopus 로고    scopus 로고
    • NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
    • Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature, 493:674-678.
    • (2013) Nature , vol.493 , pp. 674-678
    • Heneka, M.T.1    Kummer, M.P.2    Stutz, A.3    Delekate, A.4    Schwartz, S.5    Vieira-Saecker, A.6
  • 155
    • 0033966340 scopus 로고    scopus 로고
    • Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
    • Licastro F, Pedrini S, Caputo L, Annoni G, Grimaldi LME (2000). Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol, 103:97-102.
    • (2000) J Neuroimmunol , vol.103 , pp. 97-102
    • Licastro, F.1    Pedrini, S.2    Caputo, L.3    Annoni, G.4    Grimaldi, L.M.E.5
  • 156
    • 33645082486 scopus 로고    scopus 로고
    • Potential Inflammatory biomarkers in Alzheimer's disease
    • Mraka RE, Griffin WST (2005). Potential Inflammatory biomarkers in Alzheimer's disease. J Alzheimers Dis, 8:369-375.
    • (2005) J Alzheimers Dis , vol.8 , pp. 369-375
    • Mraka, R.E.1    Griffin, W.S.T.2
  • 158
    • 0032406078 scopus 로고    scopus 로고
    • Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1β, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-α, the soluble tumor necrosis factor receptors I and II, and α1 antichymotrypsin
    • Lanzrein A, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD (1998). Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1β, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-α, the soluble tumor necrosis factor receptors I and II, and α1 antichymotrypsin. Alzheimer Dis Assoc Disord, 12: 215-227.
    • (1998) Alzheimer Dis Assoc Disord , vol.12 , pp. 215-227
    • Lanzrein, A.1    Johnston, C.M.2    Perry, V.H.3    Jobst, K.A.4    King, E.M.5    Smith, A.D.6
  • 160
    • 84914705872 scopus 로고    scopus 로고
    • Raised serum proinflammatory cytokines in Alzheimer's disease with depression
    • Khemka VK, Ganguly A, Bagchi D, Ghosh A, Bir A, Biswas A, et al. (2014). Raised serum proinflammatory cytokines in Alzheimer's disease with depression. Aging Dis, 5:170-176.
    • (2014) Aging Dis , vol.5 , pp. 170-176
    • Khemka, V.K.1    Ganguly, A.2    Bagchi, D.3    Ghosh, A.4    Bir, A.5    Biswas, A.6
  • 161
    • 0043074630 scopus 로고    scopus 로고
    • Entry of Blood-Borne Cytokines into the Central Nervous System: Effects on Cognitive Processes
    • Banks WA, Farr SA, Morley JE (2002). Entry of Blood-Borne Cytokines into the Central Nervous System: Effects on Cognitive Processes. Neuroimmunomodulation, 10:319-327.
    • (2002) Neuroimmunomodulation , vol.10 , pp. 319-327
    • Banks, W.A.1    Farr, S.A.2    Morley, J.E.3
  • 163
    • 59249085094 scopus 로고    scopus 로고
    • Evidence for a cytokine model of cognitive function
    • McAfoose J, Baune BT (2009). Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev, 33:355-366.
    • (2009) Neurosci Biobehav Rev , vol.33 , pp. 355-366
    • McAfoose, J.1    Baune, B.T.2
  • 164
    • 23444443814 scopus 로고    scopus 로고
    • Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system
    • Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, et al. (2005). Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J, 19:1329-1331.
    • (2005) FASEB J , vol.19 , pp. 1329-1331
    • Godbout, J.P.1    Chen, J.2    Abraham, J.3    Richwine, A.F.4    Berg, B.M.5    Kelley, K.W.6
  • 167
    • 37249094173 scopus 로고    scopus 로고
    • From inflammation to sickness and depression: when the immune system subjugates the brain
    • Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci, 9:46-56.
    • (2008) Nat Rev Neurosci , vol.9 , pp. 46-56
    • Dantzer, R.1    O'Connor, J.C.2    Freund, G.G.3    Johnson, R.W.4    Kelley, K.W.5
  • 169
    • 42649084052 scopus 로고    scopus 로고
    • The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
    • Shaftel SS, Griffin WS, O'Banion MK (2008). The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation, 5:7.
    • (2008) J Neuroinflammation , vol.5 , pp. 7
    • Shaftel, S.S.1    Griffin, W.S.2    O'Banion, M.K.3
  • 170
    • 0032621790 scopus 로고    scopus 로고
    • TNF alpha plus IFN gamma induce the production of Alzheimer beta-amyloid peptides, and decrease the secretion of APPs
    • Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B (1999). TNF alpha plus IFN gamma induce the production of Alzheimer beta-amyloid peptides, and decrease the secretion of APPs. FASEB J, 13:63-68.
    • (1999) FASEB J , vol.13 , pp. 63-68
    • Blasko, I.1    Marx, F.2    Steiner, E.3    Hartmann, T.4    Grubeck-Loebenstein, B.5
  • 171
    • 0031755168 scopus 로고    scopus 로고
    • Current understanding of the molecular actions of vitamin D
    • Jones G, Strugnell SA, DeLuca HF (1998). Current understanding of the molecular actions of vitamin D. Physiol Rev, 78:1193-1231.
    • (1998) Physiol Rev , vol.78 , pp. 1193-1231
    • Jones, G.1    Strugnell, S.A.2    DeLuca, H.F.3
  • 174
    • 84875275487 scopus 로고    scopus 로고
    • Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease
    • Eyles DW, Burne TH, McGrath JJ (2013). Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol, 34:47-64.
    • (2013) Front Neuroendocrinol , vol.34 , pp. 47-64
    • Eyles, D.W.1    Burne, T.H.2    McGrath, J.J.3
  • 176
    • 34548051122 scopus 로고    scopus 로고
    • Association between vitamin D receptor gene polymorphism and Alzheimer's disease
    • Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gürvit H, Emre M, et al. (2007). Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med, 12:275-282.
    • (2007) Tohoku J Exp Med , vol.12 , pp. 275-282
    • Gezen-Ak, D.1    Dursun, E.2    Ertan, T.3    Hanagasi, H.4    Gürvit, H.5    Emre, M.6
  • 178
    • 84867850716 scopus 로고    scopus 로고
    • Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease
    • Gezen-Ak D, Dursun E, Bilgiç B, Hanagasi H, Ertan T, Gürvit H, et al. (2012). Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J Exp Med, 228:189-196.
    • (2012) Tohoku J Exp Med , vol.228 , pp. 189-196
    • Gezen-Ak, D.1    Dursun, E.2    Bilgiç, B.3    Hanagasi, H.4    Ertan, T.5    Gürvit, H.6
  • 179
    • 84872468949 scopus 로고    scopus 로고
    • Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis
    • Annweiler C, Llewellyn DJ, Beauchet O (2013). Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis, 33:659-674.
    • (2013) J Alzheimers Dis , vol.33 , pp. 659-674
    • Annweiler, C.1    Llewellyn, D.J.2    Beauchet, O.3
  • 180
    • 84877623263 scopus 로고    scopus 로고
    • Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis
    • Zhao Y, Sun Y, Ji HF, Shen L (2013). Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis. Nutrition, 29:828-832.
    • (2013) Nutrition , vol.29 , pp. 828-832
    • Zhao, Y.1    Sun, Y.2    Ji, H.F.3    Shen, L.4
  • 181
    • 84899636058 scopus 로고    scopus 로고
    • Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia
    • Afzal S, Bojesen SE, Nordestgaard BG (2014). Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia. Alzheimers Dement, 10:296-302.
    • (2014) Alzheimers Dement , vol.10 , pp. 296-302
    • Afzal, S.1    Bojesen, S.E.2    Nordestgaard, B.G.3
  • 182
    • 84906214032 scopus 로고    scopus 로고
    • Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes
    • [Epub ahead of print]
    • Hooshmand B, Lokk J, Solomon A, Mangialasche F, Miralbell J, Spulber G, et al. (2014). Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes. J Gerontol A Biol Sci Med Sci, doi: 10.1093/gerona/glu022 [Epub ahead of print].
    • (2014) J Gerontol A Biol Sci Med Sci
    • Hooshmand, B.1    Lokk, J.2    Solomon, A.3    Mangialasche, F.4    Miralbell, J.5    Spulber, G.6
  • 183
    • 79951563916 scopus 로고    scopus 로고
    • A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons
    • Dursun E, Gezen-Ak D, Yilmazer S (2011). A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. J Alzheimers Dis, 23:207-219.
    • (2011) J Alzheimers Dis , vol.23 , pp. 207-219
    • Dursun, E.1    Gezen-Ak, D.2    Yilmazer, S.3
  • 184
    • 0026597610 scopus 로고
    • Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels
    • Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR (1992). Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res, 13:239-250.
    • (1992) Brain Res Mol Brain Res , vol.13 , pp. 239-250
    • Sutherland, M.K.1    Somerville, M.J.2    Yoong, L.K.3    Bergeron, C.4    Haussler, M.R.5    McLachlan, D.R.6
  • 185
    • 84856269555 scopus 로고    scopus 로고
    • 1 alpha, 25-dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide (1-40) from mouse brain across the blood-brain barrier
    • Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, Terasaki T (2011). 1 alpha, 25-dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide (1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS, 8:20.
    • (2011) Fluids Barriers CNS , vol.8 , pp. 20
    • Ito, S.1    Ohtsuki, S.2    Nezu, Y.3    Koitabashi, Y.4    Murata, S.5    Terasaki, T.6
  • 186
    • 67849110353 scopus 로고    scopus 로고
    • 1 alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients
    • Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, et al. (2009). 1 alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis, 17:703-717.
    • (2009) J Alzheimers Dis , vol.17 , pp. 703-717
    • Masoumi, A.1    Goldenson, B.2    Ghirmai, S.3    Avagyan, H.4    Zaghi, J.5    Abel, K.6
  • 187
    • 79960701615 scopus 로고    scopus 로고
    • Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice
    • Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, et al. (2011).Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice. J Alzheimers Dis, 25:295-307.
    • (2011) J Alzheimers Dis , vol.25 , pp. 295-307
    • Yu, J.1    Gattoni-Celli, M.2    Zhu, H.3    Bhat, N.R.4    Sambamurti, K.5    Gattoni-Celli, S.6
  • 188
    • 84865576332 scopus 로고    scopus 로고
    • Novel disease-modifying therapies for Alzheimer's disease
    • Jiang T, Yu JT, Tan L (2012). Novel disease-modifying therapies for Alzheimer's disease. J Alzheimers Dis, 31: 475-492.
    • (2012) J Alzheimers Dis , vol.31 , pp. 475-492
    • Jiang, T.1    Yu, J.T.2    Tan, L.3
  • 189
    • 79955663447 scopus 로고    scopus 로고
    • When will Alzheimer's disease be cured? A pharmaceutical perspective
    • Townsend M (2011). When will Alzheimer's disease be cured? A pharmaceutical perspective. J Alzheimers Dis, 24 Suppl 2:43-52.
    • (2011) J Alzheimers Dis , vol.24 , pp. 43-52
    • Townsend, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.